Skip to main content
Log in

Tumortyp- und tumorstadienorientiertes chirurgisches Konzept bei Karzinomen der Schilddrüse

Tumor type and stage-oriented surgical concept for thyroid carcinoma

  • Leitthema
  • Published:
Der Onkologe Aims and scope

Zusammenfassung

Die chirurgische Therapie der Schilddrüsenkarzinome hat in den letzten Jahren aufgrund verfeinerter Techniken und Nachsorgekonzepte weltweit erhöhte Aufmerksamkeit gefunden. Wegen der tumorbiologischen Besonderheiten der 5 Haupttypen der Schilddrüsenkarzinome und der hiermit in Verbindung stehenden unterschiedlichen adjuvanten (Radiojodtherapie) bzw. additiven (Radiojodtherapie, externe Strahlentherapie, Chemotherapie) Therapieverfahren steht der primäre Karzinomtyp im Mittelpunkt der chirurgischen Therapiestratifizierung. Abhängig von der Ausdehnung des Primärtumors (extrathyreoidal vs. intrathyreoidal) und vom lokoregionären Lymphknotenbefall kann ein erhebliches lokoregionäres Rezidivrisiko bestehen. Aufgrund der zwar reduzierten, aber trotz Rezidiv auch im Langzeitverlauf nicht ungünstigen Prognose ist bei Fehlen einer progredienten Fernmetastasierung insbesondere bei differenzierten und medullären Karzinomen grundsätzlich die Indikation zur Rezidivresektion gegeben. Die Diagnostik von Primärtumoren und Rezidiven konnte insbesondere durch Sonographie und PET/CT wesentlich verbessert werden und hat dadurch nicht nur zu einer früheren Diagnosestellung, sondern auch zu einem differenzierten Verständnis der Tumorbiologie beigetragen.

Abstract

In recent years surgical therapy of thyroid carcinoma has received increased attention worldwide due to refined techniques and postoperative concepts. Due to the biological characteristics of the five main types of thyroid carcinoma and the corresponding different adjuvant (radioiodine therapy) and additive (radioiodine therapy, external radiation therapy and chemotherapy) therapeutic procedures, the type of primary carcinoma is the focus of surgical therapy stratification. There can be a substantial locoregional risk of recurrence depending on the spread of the primary tumor (extrathyroidal versus intrathyroidal) and the locoregional lymph node infestation. Due to the reduced but despite recurrence not unfavorable prognosis even in the long-term, the indications for resection of recurrences are given by a lack of progressive distant metastization especially for differentiated and medullary carcinomas. The diagnostics of primary tumors and recurrences have been substantially improved especially by sonography and PET-CT and have led not only to an earlier diagnosis but also to a differentiated understanding of tumor biology.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3

Literatur

  1. Bilimoria KY, Bentrem DJ, Ko CY et al (2007) Extent of surgery affects survival for papillary thyroid cancer. Ann Surg 246:375–384

    Article  PubMed  Google Scholar 

  2. Brauckhoff M, Meinicke A, Bilkenroth U et al (2006) Long-term results and functional outcome after cervical evisceration in patients with thyroid cancer. Surgery 140:953–955

    Article  PubMed  Google Scholar 

  3. Brauckhoff M, Dralle H (2009) Zervikoviszerale Resektionen beim organüberschreitenden Schilddrüsenkarzinom. Chirurg 80:88–98

    Article  PubMed  CAS  Google Scholar 

  4. British Thyroid Association (2002) Guidelines for the management of thyroid cancer in adults. Royal College of Physicians

  5. British Thyroid Association (2007) Guidelines for the management of thyroid cancer in adults. Royal College of Physicians. Second edition

  6. Cady B, Rossi R (1988) An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 104:947–953

    PubMed  CAS  Google Scholar 

  7. Carty SE, Cooper DS, Doherty GM et al (2009) Consensus statement on the terminology and classification of central neck dissection for thyroid cancer. Thyroid 19:1153–1158

    Article  PubMed  Google Scholar 

  8. Cooper DS, Doherty GM, Haugen BR et al (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167–1214

    Article  PubMed  Google Scholar 

  9. Davies L, Welch HG (2006) Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA 295:2164–2167

    Article  PubMed  CAS  Google Scholar 

  10. Delbridge L, Barraclough B, Parky R et al (2002) Minimally invasive follicular thyroid carcinoma: completion thyroidectomy or not? ANZ J Surg 72:844–845

    PubMed  Google Scholar 

  11. DeLellis RA, Lloyd RV, Heitz PU, Eng C (eds) (2004) Pathology and generetics of tumors of endocrine organs: World health organization classification of tumors. IARC Press, Lyon

  12. Dralle H, Scheumann GFW, Meyer HJ et al (1992) Cervical procedure at the aerodigestive tract in advanced thyroid cancer. Chirurg 63:282–290

    PubMed  CAS  Google Scholar 

  13. Dralle H, Scheumann GFW, Hundeshagen H et al (1992) Die transsternale zervikomediastinale Primärtumorresektion und Lymphadenektomie beim Schilddrüsenkarzinom. Langenbecks Arch Surg 377:34–44

    CAS  Google Scholar 

  14. Dralle H, Scheumann GFW, Kotzerke J, Brabant EG (1992) Surgical management of MEN 2. Rec Res Cancer Res 125:167–195

    CAS  Google Scholar 

  15. Dralle H, Damm I, Scheumann GFW et al (1994) Compartment-oriented microdissection of regional lymph nodes in medullary thyroid carcinoma. Surg Today 24:112–121

    Article  PubMed  CAS  Google Scholar 

  16. Dralle H, Gimm O (1996) Lymphadenektomie beim Schilddrüsenkarzinom. Chirurg 67:788–806

    Article  PubMed  CAS  Google Scholar 

  17. Dralle H, Gimm O, Simon D et al (1998) Prophylactic thyroidectomy in 75 children and adolescents with hereditary medullary thyroid carcinoma: German and Austrian experience. World J Surg 22:744–751

    Article  PubMed  CAS  Google Scholar 

  18. Dralle H, Brauckhoff M, Machens A, Gimm O (2005) Surgical management of advanced thyroid cancer invading the aerodigestive tract. In: Clark OH, Duh QY, Kebebew E (eds) Textbook on endocrine surgery. 2nd edn. Elsevier Saunders, Philadelphia, p 318–333

  19. Dralle H, Machens A (2008) Surgical approaches in thyroid cancer and lymph-node metastases. Best Pract Res Clin Endocrinol Metab 22:971–987

    Article  PubMed  Google Scholar 

  20. Dralle H, Machens A, Lorenz K (2008) Hereditäre Schilddrüsenkarzinome. Chirurg 79:1017–1028

    Article  PubMed  CAS  Google Scholar 

  21. Dralle H, Lorenz K, Machens A, Nguyen TP (2009) Postoperativer Zufallsbefund Schilddrüsenkarzinom: chirurgisches Konzept. Dtsch Med Wochenschr 134:2517–2520

    Article  PubMed  CAS  Google Scholar 

  22. Dralle H, Lorenz K, Machens A (2009) Chirurgie der Schilddrüsenkarzinome. Chirurg 80:1069–1083

    Article  PubMed  CAS  Google Scholar 

  23. Dralle H, Machens A (2009) Lymph node dissection in thyroid cancer. In: Hubbard JGH, Inabnet WB, Lo CY (eds) Endocrine Surgery. Springer, London, pp 173–193

  24. Garbe C, Albers P, Beckmann MW et al (2006) Kurzgefaßte interdisziplinäre Leitlinien 2006. Deutsche Krebsgesellschaft e. V. Zuckschwerdt, München, S53–S61

  25. Grillo HC, Suen HC, Mathisen DJ, Wain JC (1992) Resectional management of thyroid carcinoma invading the airway. Ann Thorac Surg 54:3–10

    PubMed  CAS  Google Scholar 

  26. Grünwald F, Kalicke T, Feine U et al (1999) Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: results of a multicentre study. Eur J Nucl Med Mol Imaging 26:1547–1552

    Article  Google Scholar 

  27. Hartel W, Junginger TH (1996) Leitlinien der Therapie maligner Schiddrüsentumoren. Beilage zu den Mitteilungen der Deutschen Gesellschaft für Chirurgie. Heft 3

  28. Ito Y, Tomoda C, Uruno T et al (2004) Papillary microcarcinoma of the thyroid: how should it be treated? World J Surg 28:1115–1121

    Article  PubMed  Google Scholar 

  29. Ito Y, Uruno T, Takamura Y et al (2005) Papillary microcarcinomas of the thyroid with preoperatively detectable lymph node metastasis show significantly higher agressive characteristics on immuno-histochemical examination.Oncology 68:87–96

    Article  PubMed  CAS  Google Scholar 

  30. Ito Y, Jikuzono T, Higashiyama T et al (2006) Clinical significance of lymph node metastasis of thyroid papillary carcinoma located in one lobe. World J Surg 30:1821–1828

    Article  PubMed  Google Scholar 

  31. Ito Y, Tomoda C, Uruno T et al (2006) Clinical significance of metastasis to the central compartment from papillary microcarcinoma of the thyroid. World J Surg 30:91–99

    Article  PubMed  Google Scholar 

  32. Ito Y, Miyauchi A (2007) Lateral and mediastinale lymph node dissection in differentiated thyroid carcinoma: indications, benefits, and risks. World J Surg 31:905–915

    Article  PubMed  Google Scholar 

  33. Kloos RT, Eng C, Evans DB et al (2009) Medullary thyroid cancer: Management guidelines of the American Thyroid Association. Thyroid 19:565–612

    Article  PubMed  Google Scholar 

  34. Kouvaraki MA, Lee JE, Shapiro SE et al (2004) Preventable reoperations for persistent and recurrent papillary thyroid carcinoma. Surgery 136:1189–1191

    Article  Google Scholar 

  35. Leboulleux S, Rubino C, Baudin E et al (2005) Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis. J Clin Endocrinol Metab 90:5723–5729

    Article  PubMed  CAS  Google Scholar 

  36. Lee YS, Kim SW, Kang HS et al (2007) Extent of routine central lymph node dissection with small papillary thyroid carcinoma. World J Surg 31:1954–1959

    Article  PubMed  Google Scholar 

  37. Machens A, Hinze R, Lautenschläger C et al (2001) Thyroid carcinoma invading the cervicovisceral axis: routes of invasion and clinical implications. Surgery 129:23–28

    Article  PubMed  CAS  Google Scholar 

  38. Machens A, Hinze R, Lautenschläger C et al (2001) Multivariate analysis of clinicopathologic parameters for the insular subtype of differentiated thyroid carcinoma. Arch Surg 136:941–944

    Article  PubMed  CAS  Google Scholar 

  39. Machens A, Lautenschläger C, Thomusch O et al (2001) Extended surgery and early postoperative radiotherapy for undifferentiated thyroid carcinoma. Thyroid 11:373–380

    Article  PubMed  CAS  Google Scholar 

  40. Machens A, Hinze R, Thomusch O et al (2002) Pattern of nodal metastasis for primary and reoperative thyroid cancer. World J Surg 26:22–28

    Article  PubMed  Google Scholar 

  41. Machens A, Niccoli-Sire P, Hoegel J (2003) Early malignant progression of hereditary medullary thyroid carcinoma. N Engl J Med 349:1517–1525

    Article  PubMed  CAS  Google Scholar 

  42. Machens A, Holzhausen HJ, Lautenschläger C et al (2003) Enhancement of lymph node metastasis and distant metastasis of thyroid carcinoma. Cancer 98:712–719

    Article  PubMed  Google Scholar 

  43. Machens A, Schneyer U, Holzhausen HJ et al (2005) Prospects of remission in medullary thyroid carcinoma according to basal calcitonin level. J Clin Endocrinol Metab 90:2029–2034

    Article  PubMed  CAS  Google Scholar 

  44. Machens A, Hauptmann S, Dralle H (2007) Increased risk of lymph node metastasis in multifocal hereditary and sporadic medullary thyroid cancer. World J Surg 31:1960–1965

    Article  PubMed  Google Scholar 

  45. Machens A, Hauptmann S, Dralle H (2008) Prediction of lateral lymph node metastases in medullary thyroid cancer. Br J Surg 95:586–591

    Article  PubMed  CAS  Google Scholar 

  46. Machens A, Lorenz K, Dralle H (2009) Individualization of lymph node dissection in RET carriers at risk for medullary thyroid cancer: value of pretherapeutic calcitonin level. Ann Surg 250:305–310

    Article  PubMed  Google Scholar 

  47. Machens A, Hauptmann S, Dralle H (2009) Lymph node dissection in the lateral neck for completion in central node-positive papillary thyorid cancer. Surgery 145:176–181

    Article  PubMed  Google Scholar 

  48. Machens A, Dralle H (2009) Prediction of mediastinal lymph node metastasis in papillary thyroid cancer. Ann Surg Oncol 16:171–176

    Article  PubMed  CAS  Google Scholar 

  49. Miyauchi A, Matsuzuka F, Hival K et al (2000) Unilateral surgery supported by germline RET oncogene mutation analysis in patients with sporadic medullary thyroid carcinoma. World J Surg 24:1367–1372

    Article  PubMed  CAS  Google Scholar 

  50. Modigliani E, Cohen R, Compos JM et al (1998) Prognostic factors for survival factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. Clin Endocrinol (Oxf) 48:265–273

    Google Scholar 

  51. Moley JF, DeBenedetti MK (1999) Patterns of nodal metastases in palpable medullary thyroid carcinoma: recommendations for extent of node dissection. Ann Surg 229:880–888

    Article  PubMed  CAS  Google Scholar 

  52. Passler C, Scheuba C, Asari R et al (2005) Importance of tumor size in papillary and follicular thyroid cancer. Br J Surg 92:184–189

    Article  PubMed  CAS  Google Scholar 

  53. Pulcrano M, Boukheris H, Talbot M et al (2007) Poorly differentiated follicular thyroid carcinoma: prognostic factors and relevance of histological classification. Thyroid 17:639–646

    Article  PubMed  Google Scholar 

  54. Qubain SW, Nakano S, Baba M et al (2002) Distribution of lymph node micrometastasis in pN0 well-differentiated thyroid carcinoma. Surgery 131:249–256

    Article  PubMed  Google Scholar 

  55. Raffel A, Cupisti K, Krausch M et al (2004) Incidentally found medullary thyroid cancer: treatment rationale for small tumors. World J Surg 28:397–401

    Article  PubMed  Google Scholar 

  56. Robbins KT, Medina JE, Wolfe GT et al (1991) Standardizing neck dissection terminology. Arch Otolaryngol Head Neck Surg 117:601–605

    PubMed  CAS  Google Scholar 

  57. Robbins KT, Clayman G, Levine PA et al (2002) And the committee for Hand and Neck Surgery and Oncology, American Academy of Otolaryngology-Head and Neck Surgery. Neck dissection classification uptdate. Arch Otolaryngol Head Neck Surg 128:751–758

    PubMed  Google Scholar 

  58. Robbins RJ, Wan Q, Rewal RK et al (2006) Real-time prognosis for metastatic thyroid carcinoma based on 2-[18F]fluoro-2-deoxy-D-glucose-positron emission tomography scanning. J Clin Endocrinol Metab 91:498–505

    Article  PubMed  CAS  Google Scholar 

  59. Scheumann GFW, Gimm O, Wegener G et al (1994) Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J Surg 18:559–568

    Article  PubMed  CAS  Google Scholar 

  60. Schmid KW, Farid NR (2006) How to define follicular thyroid carcinoma? Virchows Arch 448:385–393

    Article  PubMed  Google Scholar 

  61. Scollo C, Baudin E, Travagli JP et al (2003) Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer. J Clin Endocrinol Metab 88:2070–2075

    Article  PubMed  CAS  Google Scholar 

  62. Shaha A (2001) Invited commentary. Minimally invasive follicular thyroid carcinoma. Surgery 130:119–120

    Article  PubMed  CAS  Google Scholar 

  63. Sobrinho-Simoes M, Noguchi SU, Mazzaferri EL et al (2004) In: DeLellis RA, Lloyd RV, Heitz PU (eds) Tumours of endocrine organs. Pathology and genetics. World Health Organization classification of tumours. IARC Press, Lyon

  64. Sugitani I, Kasai N, Fujimoto Y et al (2004) A novel classification system for patients with PTC: addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up period. Surgery 135:139–148

    Article  PubMed  Google Scholar 

  65. Sywak M, Cornfod L, Roach P et al (2006) Routine ipsilateral level 6 lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer. Surgery 140:1000–1007

    Article  PubMed  Google Scholar 

  66. Vasko V, Hu S, Wu G et al (200s5) High prevalence and possible de novo formation of BRAF mutation in metastasized papillary thyroid cancer in lymph node. J Clin Endocrinol Metab 90:5265–5269

    Article  CAS  Google Scholar 

  67. Wada N, Duh QY, Sugino K et al (2003) Lymph node metastasis from 259 papillary thyroid microcarcinomas. Ann Surg 237:399–407

    Article  PubMed  Google Scholar 

  68. White ML, Gauger PG, Doherty GM (2007) Central lymph node dissection in differentiated thyroid cancer. World J Surg 31:895–904

    Article  PubMed  Google Scholar 

  69. Wittekind CH, Greene FL, Henson DE et al (2003) TNM supplement. 3rd ed. Wiley-Liss, New York. 25–30

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H. Dralle FRCS, FACS.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dralle, H., Lorenz, K., Machens, A. et al. Tumortyp- und tumorstadienorientiertes chirurgisches Konzept bei Karzinomen der Schilddrüse. Onkologe 16, 666–677 (2010). https://doi.org/10.1007/s00761-010-1868-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00761-010-1868-9

Schlüsselwörter

Keywords

Navigation